Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
- Market Cap ₹ 6,853 Cr.
- Current Price ₹ 551
- High / Low ₹ 584 / 214
- Stock P/E 207
- Book Value ₹ 10.1
- Dividend Yield 0.15 %
- ROCE 52.4 %
- ROE 40.8 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 54.5 times its book value
- Promoter holding has decreased over last quarter: -2.31%
- Debtor days have increased from 30.9 to 39.4 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
147 | 205 | |
128 | 159 | |
Operating Profit | 18 | 46 |
OPM % | 12% | 22% |
1 | 3 | |
Interest | 1 | 1 |
Depreciation | 3 | 3 |
Profit before tax | 15 | 44 |
Tax % | 26% | 24% |
11 | 34 | |
EPS in Rs | 1.23 | 2.72 |
Dividend Payout % | 0% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 40% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 212% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 208% |
1 Year: | 140% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 41% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
Equity Capital | 10 | 14 |
Reserves | 26 | 112 |
7 | 1 | |
18 | 24 | |
Total Liabilities | 62 | 151 |
29 | 60 | |
CWIP | 5 | 1 |
Investments | 0 | 5 |
28 | 86 | |
Total Assets | 62 | 151 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
16 | 15 | |
-18 | -33 | |
-5 | 48 | |
Net Cash Flow | -7 | 29 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
Debtor Days | 23 | 39 |
Inventory Days | 149 | 85 |
Days Payable | 109 | 126 |
Cash Conversion Cycle | 62 | -1 |
Working Capital Days | -12 | 28 |
ROCE % | 52% |
Documents
Announcements
-
Updates
2 August 2025 - Jeena Sikho Lifecare gets in-principle approval to migrate shares from NSE SME to NSE and BSE main boards.
-
Change in Company Secretary/Compliance Officer
1 August 2025 - Company Secretary Anshika Garg resigns effective 1 Aug 2025, disclosed as per SEBI regulations.
-
Resignation
1 August 2025 - Company Secretary Anshika Garg resigned effective 1 August 2025, per SEBI regulations.
-
Product launch
1 August 2025 - Jeena Sikho Lifecare launches Ayurveda OTC product 'Pet Yakriti Pliha Shuddhi Kit' on 1 Aug 2025.
-
Updates
30 July 2025 - Jeena Sikho Lifecare publishes multiple Ayurvedic case studies on chronic diseases authored by MD and experts.
Annual reports
Concalls
-
Jul 2025TranscriptNotesPPTREC
-
May 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptNotesPPT REC
-
May 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
Business Segment
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 1,530 operational beds, with another 518 beds in the pipeline.